The tick season in Maine this year remains active with numbers of some human tickborne illnesses so far in 2024 surpassing incidence rates of earlier years. The purpose of this health advisory is to remind clinicians to consider tickborne infection testing in patients presenting with febrile illnesses at any time of the year, including this fall when deer ticks are active.
Please take a moment to review this timely information from the U.S. CDC about disruptions in certain products from the Baxter International Facility in North Carolina impacted by Hurricane Helene. Federal agencies are working with Baxter and with other manufacturers to restore production capacity for these products as soon as possible.
Please review this information from the U.S. CDC on the Marburg virus disease outbreak in Rwanda and the federal response to it. Further information is provided here for Maine facilities and providers. No confirmed cases of MVD related to this outbreak have been reported in the United States or other countries outside of the Republic of Rwanda to date.
Any patients with confirmed or suspected Marburg virus disease must be reported immediately to Maine CDC by phone at 800-821-5821.
Ground-level particle pollution concentrations are expected to reach the 'Unhealthy for Sensitive Groups' (USG) level in the Eastern Interior and Mid-Coast Regions for today and tomorrow according to Air Quality Meteorologists at the Maine Department of Environmental Protection.
Please take a moment to review this information from U.S. CDC on mpox prevention in travelers to countries with clade I mpox outbreaks.
Arboviral activity is high in Maine and across the northeast U.S. region. Maine has detected Eastern Equine Encephalitis (EEE), Jamestown Canyon virus (JCV), and West Nile virus (WNV) in mosquitoes, wild birds, domestic animals, and/or humans in 13 of our 16 counties. The purpose of this health advisory is to remind clinicians to test for mosquito-borne arboviruses in appropriate patients.
Please review this information about an increased risk of Oropouche virus (OROV) infection in the U.S. associated with an increase in global Oropouche activity and key actions clinicians can take to recognize Oropouche, order appropriate testing, ensure timely reporting to public health authorities, and promote prevention measures.
The arboviral season in Maine is ramping up. The purpose of this health advisory is to remind clinicians to consider testing for mosquito-borne arboviruses in patients presenting with unexplained flu-like symptoms, encephalitis, meningitis, or high fever (100.4F or 38C) during the summer and fall.
The U.S. Centers for Disease Control and Prevention (U.S. CDC) is issuing this Health Alert Network (HAN) Health Advisory to notify healthcare providers, public health authorities, and the public about current increases in human parvovirus B19 activity in the United States. Parvovirus B19 is a seasonal respiratory virus that is transmitted through respiratory droplets by people with symptomatic or asymptomatic infection. In the first quarter of 2024, public health authorities in 14 European countries observed unusually high numbers of cases of parvovirus B19.
Please take a moment to review this information from U.S. CDC on mpox transmission in the Democratic Republic of the Congo (DRC) and neighboring countries that involves monkeypox virus Clade I. No cases of clade I mpox have been reported outside central and eastern Africa at this time.
